A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1)
Condition(s):Cancer; Non Small Cell Lung CancerLast Updated:October 7, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Cancer; Non Small Cell Lung CancerLast Updated:October 7, 2021Completed
Condition(s):Pancreatic AdenocarcinomaLast Updated:February 23, 2024Recruiting
Condition(s):Participants of Longitudinal Cohort Studies; ControlsLast Updated:January 19, 2021Unknown status
Condition(s):Prostate CancerLast Updated:November 25, 2020Completed
Condition(s):Breast Cancer; Quality of Life; Surgery–ComplicationsLast Updated:June 6, 2023Active, not recruiting
Condition(s):Lipedema; Dercum DiseaseLast Updated:February 8, 2024Completed
Condition(s):Brain Metastasis; NeoplasmLast Updated:December 3, 2015Completed
Condition(s):Primary HyperparathyroidismLast Updated:January 9, 2024Terminated
Condition(s):Uterine Cervical CancerLast Updated:May 15, 2014Enrolling by invitation
Condition(s):Cerebrovascular Accident; Transient Ischemic Attack; Myocardial InfarctionLast Updated:August 11, 2009Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.